Johnson & Johnson quarterly profit jumps 41.8%

The Johnson & Johnson logo is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, U.S., May 29, 2019. REUTERS/Brendan McDermid - Copyright BRENDAN MCDERMID(Reuters)

By Reuters

Published on 16/07/2019 - 13:04•Updated 30/04/2024 - 04:17

Comments

(Reuters) - Johnson & Johnson <JNJ.N> reported a 41.8% rise in second-quarter profit on Tuesday, helped by its pharmaceuticals business.

The diversified healthcare company, the first major U.S. drugmaker to report second-quarter results, said net earnings rose to $5.61 billion (£4.51 billion), or $2.08 per share, from $3.95 billion, or $1.45 per share, a year earlier.

Sales fell 1.3% to $20.56 billion.

(Reporting by Manas Mishra and Manojna Maddipatla in Bengaluru; Editing by Sriraj Kalluvila)

Comments

You might also like